Brett S Carver Selected Research

Nonseminomatous germ cell tumor

8/2018	Histologic and Oncologic Outcomes Following Liver Mass Resection With Retroperitoneal Lymph Node Dissection in Patients With Nonseminomatous Germ Cell Tumor.
2/2009	Preservation of ejaculation in patients undergoing nerve-sparing postchemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer.
2/2008	The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor.
10/2007	Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
7/2005	The current status of laparoscopic retroperitoneal lymph node dissection for non-seminomatous germ-cell tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brett S Carver Research Topics

Disease

30	Neoplasms (Cancer) 10/2021 - 02/2004
28	Prostatic Neoplasms (Prostate Cancer) 10/2020 - 02/2004
19	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2021 - 07/2006
9	Teratoma (Teratoid Tumor) 01/2019 - 07/2006
7	Testicular Neoplasms (Testicular Cancer) 04/2018 - 03/2007
6	Carcinogenesis 04/2016 - 05/2009
6	Neoplasm Metastasis (Metastasis) 07/2014 - 08/2002
5	Nonseminomatous germ cell tumor 08/2018 - 07/2005
3	Fibrosis (Cirrhosis) 01/2019 - 02/2007
3	Margins of Excision 09/2017 - 02/2007
3	Disease Progression 05/2012 - 08/2006
2	Embryonal Carcinoma 04/2018 - 01/2017
2	Wounds and Injuries (Trauma) 01/2014 - 05/2004
2	Prostatitis 02/2003 - 04/2002
1	Malignant Mesothelioma 09/2017
1	Necrosis 01/2017
1	Residual Neoplasm 02/2015
1	Sex Cord-Gonadal Stromal Tumors (Sex Cord-Stromal Tumor) 08/2014
1	medullary Thyroid cancer 01/2014
1	Seminoma 10/2011
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2009
1	Genetic Translocation (Chromosomal Translocation) 05/2009
1	Multiple Hamartoma Syndrome (Cowden's Disease) 01/2007
1	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 07/2006
1	Lower Urinary Tract Symptoms 03/2005
1	Hematuria 05/2004
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2002
1	Adenocarcinoma 04/2002
1	Granular Cell Tumor 04/2002

Drug/Important Bio-Agent (IBA)

7	Androgen Receptors (Androgen Receptor)IBA 01/2019 - 05/2011
7	AndrogensIBA 10/2017 - 08/2007
7	Prostate-Specific Antigen (Semenogelase)IBA 11/2014 - 04/2002
5	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 02/2015
5	Biological ProductsIBA 01/2018 - 07/2006
4	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 02/2015
3	Hormones (Hormone)IBA 10/2020 - 08/2006
3	Phosphotransferases (Kinase)IBA 01/2015 - 05/2011
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 02/2015
2	Androgen Antagonists (Antiandrogens)IBA 10/2020 - 11/2013
2	Messenger RNA (mRNA)IBA 01/2019 - 07/2010
2	Protein Isoforms (Isoforms)IBA 01/2018 - 01/2015
2	Tumor Biomarkers (Tumor Markers)IBA 08/2015 - 12/2013
2	Transcription Factors (Transcription Factor)IBA 05/2015 - 02/2009
2	Biomarkers (Surrogate Marker)IBA 11/2014 - 07/2014
2	Indicators and Reagents (Reagents)IBA 11/2014 - 08/2002
2	Tumor Suppressor Protein p14ARF (p14ARF)IBA 10/2014 - 08/2009
2	DNA (Deoxyribonucleic Acid)IBA 07/2014 - 07/2010
2	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 08/2011 - 05/2009
1	RNA (Ribonucleic Acid)IBA 10/2021
1	Insulin-Like PeptidesIBA 01/2021
1	Neuregulin-1 (Neuregulin 1)IBA 10/2020
1	Blocking AntibodiesIBA 10/2020
1	NexusIBA 01/2019
1	Eukaryotic Initiation Factor-4F (EIF4F)IBA 01/2019
1	HydrolasesIBA 01/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018
1	AntigensIBA 01/2018
1	sapanisertibIBA 01/2018
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2018
1	Mechanistic Target of Rapamycin Complex 1IBA 10/2017
1	Aurora Kinase AIBA 04/2016
1	Docetaxel (Taxotere)FDA Link 05/2015
1	tyrosine receptor (receptor, tyrosine)IBA 01/2015
1	Exopeptidases (Exopeptidase)IBA 11/2014
1	AminopeptidasesIBA 11/2014
1	Proteins (Proteins, Gene)FDA Link 11/2014
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 11/2014
1	CateninsIBA 10/2014
1	Cadherins (E-Cadherin)IBA 10/2014
1	Technetium (Technetium 99m)IBA 01/2014
1	cabozantinibIBA 01/2014
1	Pharmaceutical PreparationsIBA 01/2014
1	FluoridesIBA 01/2014
1	Radioisotopes (Radionuclides)IBA 01/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2014
1	PlatinumIBA 01/2012
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2011
1	Fetal Proteins (Fetoprotein)IBA 10/2011
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 08/2011
1	MTOR InhibitorsIBA 03/2011
1	Phosphatidylinositols (Phosphatidylinositol)IBA 03/2011
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 07/2010
1	taxaneIBA 02/2007
1	Lysine (L-Lysine)FDA Link 01/2007
1	Finasteride (Propecia)FDA LinkGeneric 03/2005
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2002

Therapy/Procedure

24	Lymph Node Excision (Lymph Node Dissection) 01/2020 - 08/2002
17	Drug Therapy (Chemotherapy) 01/2021 - 07/2006
13	Therapeutics 10/2020 - 03/2005
8	Prostatectomy (Retropubic Prostatectomy) 10/2009 - 04/2002
5	Castration 10/2020 - 11/2013
4	Orchiectomy (Orchidectomy) 04/2018 - 07/2006
2	Induction Chemotherapy 02/2015 - 02/2008
2	Nephrectomy 09/2009 - 02/2007
1	Adjuvant Chemotherapy 01/2020
1	Aftercare (After-Treatment) 02/2015
1	Radiotherapy 11/2013
1	Salvage Therapy 02/2007
1	Laparotomy 05/2004